{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:02:00Z","timestamp":1790488920711,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T00:00:00Z","timestamp":1160611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T00:00:00Z","timestamp":1160611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,12,1]]},"DOI":"10.1038\/sj.leu.2404420","type":"journal-article","created":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T11:38:33Z","timestamp":1160653113000},"page":"2155-2161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)\/E2A-PBX1 and t(4;11)\/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study"],"prefix":"10.1038","volume":"20","author":[{"given":"N","family":"Vey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kovascovicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Charin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Cayuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Dastugue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Stamatoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Giollant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Buzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kuentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dreyfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Delannoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Gratecos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bordessoule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"de Botton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Preudhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Reman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Troussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pigneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bilhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P","family":"Vernant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Boucheix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For The GET-LALA Group the Swiss Group for Clinical Cancer Research (SAKK)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,12]]},"reference":[{"key":"BF2404420_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000; 18: 547\u2013561.","journal-title":"J Clin Oncol"},{"key":"BF2404420_CR2","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1200\/JCO.1993.11.10.1990","volume":"11","author":"D Fiere","year":"1993","unstructured":"Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. J Clin Oncol 1993; 11: 1990\u20132001.","journal-title":"J Clin Oncol"},{"key":"BF2404420_CR3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","volume":"85","author":"RA Larson","year":"1995","unstructured":"Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood 1995; 85: 2025\u20132037.","journal-title":"Blood"},{"key":"BF2404420_CR4","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S0889-8588(05)70188-X","volume":"14","author":"N Gokbuget","year":"2000","unstructured":"Gokbuget N, Hoelzer D, Arnold R, Bohme A, Bartram CR, Freund M et al. Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am 2000; 14: 1307\u20131325, ix.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF2404420_CR5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood.V71.1.123.123","volume":"71","author":"D Hoelzer","year":"1988","unstructured":"Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123\u2013131.","journal-title":"Blood"},{"key":"BF2404420_CR6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","volume":"87","author":"D Hoelzer","year":"1996","unstructured":"Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Loffler H, Fonatsch C et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495\u2013508.","journal-title":"Blood"},{"key":"BF2404420_CR7","first-page":"1898","volume":"92","author":"WD Ludwig","year":"1998","unstructured":"Ludwig WD, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03\/87 and 04\/89. Blood 1998; 92: 1898\u20131909.","journal-title":"Blood"},{"key":"BF2404420_CR8","first-page":"154","volume":"87","author":"JM Ribera","year":"2002","unstructured":"Ribera JM, Ortega JJ, Oriol A, Granada I, Hernandez-Rivas JM, Parody R et al. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Haematologica 2002; 87: 154\u2013166.","journal-title":"Haematologica"},{"key":"BF2404420_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x","volume":"96","author":"LM Secker-Walker","year":"1997","unstructured":"Secker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E, Harrison G . Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol 1997; 96: 601\u2013610.","journal-title":"Br J Haematol"},{"key":"BF2404420_CR10","first-page":"3983","volume":"93","author":"M Wetzler","year":"1999","unstructured":"Wetzler M, Dodge RK, Mrozek K, Carroll AJ, Tantravahi R, Block AW et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood 1999; 93: 3983\u20133993.","journal-title":"Blood"},{"key":"BF2404420_CR11","doi-asserted-by":"crossref","unstructured":"A Collaborative Study of the Group Francais de Cytogenetique Hematologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. Blood 1996; 87: 3135\u20133142.","DOI":"10.1182\/blood.V87.8.3135.bloodjournal8783135"},{"key":"BF2404420_CR12","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","volume":"100","author":"H Dombret","year":"2002","unstructured":"Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia-results of the prospective multicenter LALA-94 trial. Blood 2002; 100: 2357\u20132366.","journal-title":"Blood"},{"key":"BF2404420_CR13","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1182\/blood-2001-12-0181","volume":"100","author":"OG Ottmann","year":"2002","unstructured":"Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002; 100: 1965\u20131971.","journal-title":"Blood"},{"key":"BF2404420_CR14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344: 1038\u20131042.","journal-title":"N Engl J Med"},{"key":"BF2404420_CR15","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/cncr.11664","volume":"98","author":"S Faderl","year":"2003","unstructured":"Faderl S, Jeha S, Kantarjian HM . The biology and therapy of adult acute lymphoblastic leukemia. Cancer 2003; 98: 1337\u20131354.","journal-title":"Cancer"},{"key":"BF2404420_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"CH Pui","year":"1998","unstructured":"Pui CH, Evans WE . Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605\u2013615.","journal-title":"N Engl J Med"},{"key":"BF2404420_CR17","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1200\/JCO.1990.8.8.1380","volume":"8","author":"SC Raimondi","year":"1990","unstructured":"Raimondi SC, Behm FG, Roberson PK, Williams DL, Pui CH, Crist WM et al. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 1990; 8: 1380\u20131388.","journal-title":"J Clin Oncol"},{"key":"BF2404420_CR18","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","volume":"22","author":"X Thomas","year":"2004","unstructured":"Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075\u20134086.","journal-title":"J Clin Oncol"},{"key":"BF2404420_CR19","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood.V82.10.2943.2943","volume":"82","author":"A Biondi","year":"1993","unstructured":"Biondi A, Rambaldi A, Rossi V, Elia L, Caslini C, Basso G et al. Detection of ALL-1\/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood 1993; 82: 2943\u20132947.","journal-title":"Blood"},{"key":"BF2404420_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood.V77.4.687.687","volume":"77","author":"SP Hunger","year":"1991","unstructured":"Hunger SP, Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML . The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 1991; 77: 687\u2013693.","journal-title":"Blood"},{"key":"BF2404420_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2141.1995.tb08357.x","volume":"89","author":"X Troussard","year":"1995","unstructured":"Troussard X, Rimokh R, Valensi F, Leboeuf D, Fenneteau O, Guitard AM et al. Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group. Br J Haematol 1995; 89: 516\u2013526.","journal-title":"Br J Haematol"},{"key":"BF2404420_CR22","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","volume":"13","author":"JJ van Dongen","year":"1999","unstructured":"van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901\u20131928.","journal-title":"Leukemia"},{"key":"BF2404420_CR23","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","volume":"17","author":"E Beillard","year":"2003","unstructured":"Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) \u2013 a Europe against cancer program. Leukemia 2003; 17: 2474\u20132486.","journal-title":"Leukemia"},{"key":"BF2404420_CR24","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia \u2013 a Europe Against Cancer program. Leukemia 2003; 17: 2318\u20132357.","journal-title":"Leukemia"},{"key":"BF2404420_CR25","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783\u20131786.","journal-title":"Leukemia"},{"key":"BF2404420_CR26","first-page":"1021","volume":"91","author":"SP Hunger","year":"1998","unstructured":"Hunger SP, Fall MZ, Camitta BM, Carroll AJ, Link MP, Lauer SJ et al. E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood 1998; 91: 1021\u20131028.","journal-title":"Blood"},{"key":"BF2404420_CR27","first-page":"671","volume":"7","author":"S Izraeli","year":"1993","unstructured":"Izraeli S, Janssen JW, Haas OA, Harbott J, Brok-Simoni F, Walther JU et al. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses. Leukemia 1993; 7: 671\u2013678.","journal-title":"Leukemia"},{"key":"BF2404420_CR28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V76.1.117.117","volume":"76","author":"WM Crist","year":"1990","unstructured":"Crist WM, Carroll AJ, Shuster JJ, Behm FG, Whitehead M, Vietti TJ et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood 1990; 76: 117\u2013122.","journal-title":"Blood"},{"key":"BF2404420_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1046\/j.1365-2141.2003.04113.x","volume":"120","author":"R Foa","year":"2003","unstructured":"Foa R, Vitale A, Mancini M, Cuneo A, Mecucci C, Elia L et al. E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. Br J Haematol 2003; 120: 484\u2013487.","journal-title":"Br J Haematol"},{"key":"BF2404420_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1200\/JCO.2003.02.053","volume":"21","author":"N Boissel","year":"2003","unstructured":"Boissel N, Auclerc MF, Lheritier V, Perel Y, Thomas X, Leblanc T et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003; 21: 774\u2013780.","journal-title":"J Clin Oncol"},{"key":"BF2404420_CR31","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.ejca.2003.09.005","volume":"39","author":"S Jeha","year":"2003","unstructured":"Jeha S . Who should be treating adolescents and young adults with acute lymphoblastic leukaemia? Eur J Cancer 2003; 39: 2579\u20132583.","journal-title":"Eur J Cancer"},{"key":"BF2404420_CR32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/sj.leu.2401012","volume":"12","author":"B Johansson","year":"1998","unstructured":"Johansson B, Moorman AV, Haas OA, Watmore AE, Cheung KL, Swanton S et al. Hematologic malignancies with t(4;11)(q21;q23)--a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants. Leukemia 1998; 12: 779\u2013787.","journal-title":"Leukemia"},{"key":"BF2404420_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ng765","volume":"30","author":"SA Armstrong","year":"2002","unstructured":"Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41\u201347.","journal-title":"Nat Genet"},{"key":"BF2404420_CR34","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1182\/blood-2003-03-0880","volume":"102","author":"S Schnittger","year":"2003","unstructured":"Schnittger S, Weisser M, Schoch C, Hiddemann W, Haferlach T, Kern W . New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts. Blood 2003; 102: 2746\u20132755.","journal-title":"Blood"},{"key":"BF2404420_CR35","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","volume":"359","author":"CH Pui","year":"2002","unstructured":"Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909\u20131915.","journal-title":"Lancet"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404420","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:33:55Z","timestamp":1648769635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12,1]]}},"alternative-id":["BF2404420"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404420","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,12]]},"assertion":[{"value":"8 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}